These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36354581)

  • 1. Functional Expression of the Recombinant Spike Receptor Binding Domain of SARS-CoV-2 Omicron in the Periplasm of
    Kim WS; Kim JH; Lee J; Ka SY; Chae HD; Jung I; Jung ST; Na JH
    Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36354581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
    Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
    BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
    Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
    J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant proteins of spike protein of SARS-CoV-2 with the Omicron receptor-binding domain induce production of highly Omicron-specific neutralizing antibodies.
    Kang H; Kim D; Min K; Park M; Kim SH; Sohn EJ; Choi BH; Hwang I
    Clin Exp Vaccine Res; 2022 Sep; 11(3):285-289. PubMed ID: 36451664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in
    Balasubramaniyam A; Ryan E; Brown D; Hamza T; Harrison W; Gan M; Sankhala RS; Chen WH; Martinez EJ; Jensen JL; Dussupt V; Mendez-Rivera L; Mayer S; King J; Michael NL; Regules J; Krebs S; Rao M; Matyas GR; Joyce MG; Batchelor AH; Gromowski GD; Dutta S
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant.
    Samanta A; Alam SSM; Ali S; Hoque M
    EXCLI J; 2022; 21():610-620. PubMed ID: 35651657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay.
    Tantiwiwat T; Thaiprayoon A; Siriatcharanon AK; Tachaapaikoon C; Plongthongkum N; Waraho-Zhmayev D
    Mol Biotechnol; 2023 Apr; 65(4):598-611. PubMed ID: 36103078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced binding activity of vaccine serum to omicron receptor-binding domain.
    Li M; Weng S; Wang Q; Yang Z; Wang X; Yin Y; Zhou Q; Zhang L; Tao F; Li Y; Jia M; Yang L; Xin X; Li H; Kang L; Wang Y; Wang T; Li S; Kong L
    Front Immunol; 2022; 13():960195. PubMed ID: 35967350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.
    Prahlad J; Struble LR; Lutz WE; Wallin SA; Khurana S; Schnaubelt A; Broadhurst MJ; Bayles KW; Borgstahl GEO
    Protein Sci; 2021 Sep; 30(9):1983-1990. PubMed ID: 34191362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants.
    Gelbach AL; Zhang F; Kwon SJ; Bates JT; Farmer AP; Dordick JS; Wang C; Linhardt RJ
    Front Mol Biosci; 2022; 9():912887. PubMed ID: 36046608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant expression of SARS-CoV-2 receptor binding domain (RBD) in
    Rahbar Z; Nazarian S; Dorostkar R; Sotoodehnejadnematalahi F; Amani J
    Iran J Basic Med Sci; 2022 Sep; 25(9):1110-1116. PubMed ID: 36246069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape.
    Zhao Z; Zhou J; Tian M; Huang M; Liu S; Xie Y; Han P; Bai C; Han P; Zheng A; Fu L; Gao Y; Peng Q; Li Y; Chai Y; Zhang Z; Zhao X; Song H; Qi J; Wang Q; Wang P; Gao GF
    Nat Commun; 2022 Aug; 13(1):4958. PubMed ID: 36002453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.
    Dapporto F; Marchi S; Leonardi M; Piu P; Lovreglio P; Decaro N; Buonvino N; Stufano A; Lorusso E; Bombardieri E; Ruello A; Viviani S; Molesti E; Trombetta CM; Manenti A; Montomoli E
    J Immunol Res; 2022; 2022():4813199. PubMed ID: 36093434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants.
    Gattinger P; Kratzer B; Tulaeva I; Niespodziana K; Ohradanova-Repic A; Gebetsberger L; Borochova K; Garner-Spitzer E; Trapin D; Hofer G; Keller W; Baumgartner I; Tancevski I; Khaitov M; Karaulov A; Stockinger H; Wiedermann U; Pickl WF; Valenta R
    Allergy; 2022 Aug; 77(8):2431-2445. PubMed ID: 35357709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multi-Disulfide Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Protein Expressed in
    Brindha S; Kuroda Y
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor.
    Andrade SA; Batalha-Carvalho JV; Curi R; Wen FH; Covas DT; Chudzinski-Tavassi AM; Moro AM
    Front Immunol; 2022; 13():871874. PubMed ID: 35898497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.